Ronald B Vender (Ron Vender, R Vender, Ronald Vender, R B Vender, Ron B Vender)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 62

Top Venues

Journal of cutaneous medicine and surgery

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

Dermatrials Research Inc.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dermatrials Research Inc.

Canada

Director

Publications

Eric P McMullen, Yousif A Al Naser, Mahan Maazi, Rajan S Grewal, Dana Abdel Hafeez, Tia R Folino, Ronald B Vender
Predicting psoriasis severity using machine learning: A systematic review. Clinical and experimental dermatology (2024)
Lyn C Guenther, Irina Turchin, Ronald B Vender, Lorne E Albrecht, Catherine Maari, Howard Yanofsky, Vimal H Prajapati
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and therapy 14 (7) (2024)
Mohamed Akrout, Katrina D Cirone, Ronald B Vender
Evaluation of Vision LLMs GTP-4V and LLaVA for the Recognition of Features Characteristic of Melanoma. Journal of cutaneous medicine and surgery (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Mohamed Akrout, Katrina D Cirone, Ronald B Vender
Evaluation of Vision LLMs GTP-4V and LLaVA for the Recognition of Features Characteristic of Melanoma. Journal of cutaneous medicine and surgery 28 (1) (2024)
Lyn C Guenther, Irina Turchin, Ronald B Vender, Lorne E Albrecht, Catherine Maari, Howard Yanofsky, Vimal H Prajapati
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and therapy 14 (7) (2024)
Mohamed Akrout, Katrina D Cirone, Ronald B Vender
Evaluation of Vision LLMs GTP-4V and LLaVA for the Recognition of Features Characteristic of Melanoma. Journal of cutaneous medicine and surgery 28 (1) (2024)
Andrea Chiricozzi, Giulia Coscarella, Lluis L Puig, Ronald B Vender, Jensen Yeung, Y José Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Daudén, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa, Mar Llamas Velasco, Mario Alessandri-Bonetti, Francesco Messina, Manfredo Bruni, Eugenia Veronica Di Brizzi, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Alexander J Stratigos, Miguel Nogueira, Ketty Peris, Tiago Torres
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Lyn C Guenther, Irina Turchin, Ronald B Vender, Lorne E Albrecht, Catherine Maari, Howard Yanofsky, Vimal H Prajapati
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and therapy (2024)
Lyn C Guenther, Irina Turchin, Ronald B Vender, Lorne E Albrecht, Catherine Maari, Howard Yanofsky, Vimal H Prajapati
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and therapy 14 (7) (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Ted Zhou, John Koussiouris, Lauren Kim, Ronald B Vender
Management of Guttate Psoriasis: A Systematic Review. Journal of cutaneous medicine and surgery (2024)
Vimal H Prajapati, Charles W Lynde, Melinda J Gooderham, H Chih-Ho Hong, Mark G Kirchhof, Perla Lansang, Julien Ringuet, Irina Turchin, Ronald B Vender, Jensen Yeung, Kim A Papp
Considerations for defining and diagnosing generalized pustular psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Dea Metko, Shanti Mehta, Ronald B Vender
Morphea in patients with psoriasis treated with ustekinumab: a scoping review. Archives of dermatological research 316 (8) (2024)
Lyn C Guenther, Irina Turchin, Ronald B Vender, Lorne E Albrecht, Catherine Maari, Howard Yanofsky, Vimal H Prajapati
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis. Dermatology and therapy 14 (7) (2024)
Ahmed Bagit, Khalad Maliyar, Mark Mansour, Jorge-Ryan Georgakopoulos, Brian D Rankin, Yuliya Lytvyn, Hiba Zaaroura, Ye-Jean Park, Ou Jia Emilie Wang, Asfandyar Mufti, Tiago Torres, Ana M Le, Ronald B Vender, Vimal H Prajapati, Jensen Yeung
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study. Journal of cutaneous medicine and surgery (2024)
Dea Metko, Tiago Torres, Ronald B Vender
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators? The Journal of international medical research 51 (6) (2023)
Rochelle F McAdam, Ronald B Vender
GLP-1R Agonists in Psoriasis Patients. Journal of cutaneous medicine and surgery 28 (1) (2023)
Linda F Stein Gold, Jerry Bagel, Stephen Keith Tyring, H Chih-Ho Hong, Lev Pavlovsky, Ronald B Vender, Andreas Pinter, Adam Reich, Leonidas Drogaris, Tianshuang Wu, Manish Patel, Ahmed M Soliman, Huzefa Photowala, Vassilis Stakias, Sven Richter, Kim A Papp
Comparison of risankizumab and apremilast for the treatment of adult patients with moderate plaque psoriasis eligible for systemic therapy: results from a randomised, open-label, assessor-blinded phase IV (IMMpulse) study. The British journal of dermatology (2023)
Dea Metko, Nicol Vaizman, Shanti Mehta, Ronald B Vender
Association Between Parkinson's Disease and Psoriasis: A Scoping Review. Journal of cutaneous medicine and surgery (2023)
Diamant Thaҫi, Ronald B Vender, Menno A de Rie, Curdin Conrad, David M Pariser, Bruce E Strober, Veerle Vanvoorden, Maggie Wang, Cynthia Madden, Dirk de Cuyper, Alexa B Kimball
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. The British journal of dermatology 188 (1) (2023)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy (2023)
Siddhartha Sood, Abrahim Abduelmula, Khalad Maliyar, Jorge-Ryan Georgakopoulos, Asfandyar Mufti, Ronald B Vender, Vimal H Prajapati, Jensen Yeung
Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review. Journal of cutaneous medicine and surgery (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Patrick J Kim, Rafael Paolo Lansang, Ronald B Vender
A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections. Journal of cutaneous medicine and surgery (2023)
Diamant Thaҫi, Ronald B Vender, Menno A de Rie, Curdin Conrad, David M Pariser, Bruce E Strober, Veerle Vanvoorden, Maggie Wang, Cynthia Madden, Dirk de Cuyper, Alexa B Kimball
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. The British journal of dermatology 188 (1) (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of Clinical Improvement in the Real-World Setting from Patient-Reported Psoriasis Symptoms and Signs Diary (PSSD): Secondary Outcomes from the Psoriasis Study of Health Outcomes (PSoHO) Through 12 Weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Rochelle F McAdam, Ronald B Vender
GLP-1R Agonists in Psoriasis Patients. Journal of cutaneous medicine and surgery 28 (1) (2023)
Rochelle F McAdam, Ronald B Vender
GLP-1R Agonists in Psoriasis Patients. Journal of cutaneous medicine and surgery (2023)
Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, Kim A Papp, Lyn C Guenther, Wayne P Gulliver, Vincent Ho, Neil H Shear, Ronald B Vender, Robert Gniadecki, Vimal H Prajapati, Irina Turchin, Wayne Langholff, Kim A Papp, Scott D Simpson, Nastaran Abbarin, Omair Lakhani, Raed Alhusayen
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of cutaneous medicine and surgery (2023)
Anastasia Drakos, Ronald B Vender, Tiago Torres
Topical roflumilast for the treatment of psoriasis. Expert review of clinical immunology (2023)
Brian D Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, Asfandyar Mufti, Alim R Devani, Melinda J Gooderham, H Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald B Vender, Jensen Yeung, Vimal H Prajapati
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study. The Journal of dermatological treatment 33 (5) (2022)
Ronald B Vender, Charles W Lynde
Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers. Journal of cutaneous medicine and surgery 26 (3) (2022)
Anastasia Drakos, Ronald B Vender
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians. Dermatology and therapy 12 (12) (2022)
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, Melinda J Gooderham, Parbeer Grewal, Chih-Ho Hong, Maxwell Benjamin Sauder, Ronald B Vender, Catherine Maari, Kim A Papp
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. Journal of cutaneous medicine and surgery 27 (1_suppl) (2022)
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, Melinda J Gooderham, Parbeer Grewal, Chih-Ho Hong, Maxwell Benjamin Sauder, Ronald B Vender, Catherine Maari, Kim A Papp
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. Journal of cutaneous medicine and surgery 27 (1_suppl) (2022)
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, Melinda J Gooderham, Parbeer Grewal, Chih-Ho Hong, Maxwell Benjamin Sauder, Ronald B Vender, Catherine Maari, Kim A Papp
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. Journal of cutaneous medicine and surgery 27 (1_suppl) (2022)
Jensen Yeung, Paul E Bunce, Charles W Lynde, Irina Turchin, Ronald B Vender
Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies. Journal of cutaneous medicine and surgery 26 (1_suppl) (2022)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy 12 (5) (2022)
Katrina D Cirone, Ronald B Vender
Under-Reporting of COVID-19 Infections in Psoriasis Patients on Biologics. Journal of cutaneous medicine and surgery (2022)
Wei Jing Loo, Irina Turchin, Vimal H Prajapati, Melinda J Gooderham, Parbeer Grewal, Chih-Ho Hong, Maxwell Benjamin Sauder, Ronald B Vender, Catherine Maari, Kim A Papp
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway. Journal of cutaneous medicine and surgery (2022)
Patrick M Brunner, C Conrad, Ronald B Vender, S Grond, C Schuster, H Patel, W Xu, J M Carrascosa Carrillo
Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab. The British journal of dermatology 185 (4) (2021)
Karina Nabieva, Ronald B Vender
A Useful Clinical Tool for Psoriasis. Journal of cutaneous medicine and surgery 25 (6) (2021)
Kim A Papp, Robert Gniadecki, Jennifer Beecker, Jan Dutz, Melinda J Gooderham, Chih-Ho Hong, Mark G Kirchhof, Chuck W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender
Psoriasis Prevalence and Severity by Expert Elicitation. Dermatology and therapy 11 (3) (2021)
Yuliya Lytvyn, Jorge-Ryan Georgakopoulos, A Mufti, A R Devani, M J Gooderham, V Jain, P Lansang, Ronald B Vender, V H Prajapati, J Yeung
Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Jennifer Beecker, Kim A Papp, J Dutz, Ronald B Vender, Robert Gniadecki, Curtis L Cooper, Paolo Gisondi, Melinda J Gooderham, C H Hong, M G Kirchhof, C W Lynde, C Maari, Y Poulin, Lluis L Puig
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2021)
Jorge-Ryan Georgakopoulos, A Mufti, Ronald B Vender, V H Prajapati, J Yeung
Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Abrahim Abduelmula, Jorge-Ryan Georgakopoulos, Asfandyar Mufti, Alim R Devani, Melinda J Gooderham, Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald B Vender, Vimal H Prajapati, Jensen Yeung
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study. Journal of cutaneous medicine and surgery (2021)
Heather Le, Ronald B Vender
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic [Formula: see text]. Journal of cutaneous medicine and surgery 25 (3) (2021)
Sheida Naderi-Azad, Ronald B Vender
Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text]. Journal of cutaneous medicine and surgery 25 (2) (2020)
Andrew Blauvelt, C Leonardi, Boni E Elewski, J J Crowley, L C Guenther, Melinda J Gooderham, R G Langley, Ronald B Vender, Andreas Pinter, C E M Griffiths, Y Tada, H Elmaraghy, R G Lima, G Gallo, L Renda, Russel T Burge, S Y Park, B Zhu, Kim A Papp, null null
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. The British journal of dermatology 184 (6) (2020)
Jensen Yeung, Melinda J Gooderham, Parbeer S Grewal, Chih-Ho Hong, Perla Lansang, Kim A Papp, Yves Poulin, Irina Turchin, Ronald B Vender
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper. Journal of cutaneous medicine and surgery 24 (1_suppl) (2020)
Megan Lam, Jeremy Steen, Justin Di Lu, Ronald B Vender
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis. Journal of cutaneous medicine and surgery 24 (6) (2020)
Jorge-Ryan Georgakopoulos, Ronald B Vender, Jensen Yeung
Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice. Journal of cutaneous medicine and surgery 24 (4) (2020)
Miriam Armanious, Ronald B Vender
A Review of Drug-Drug Interactions for Biologic Drugs Used in the Treatment of Psoriasis. Journal of cutaneous medicine and surgery 25 (1) (2020)
Michelle Phung, Arvin Ighani, Jorge R Georgakopoulos, Ronald B Vender, Lyne Giroux, Perla Lansang, Jensen Yeung
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis. Journal of cutaneous medicine and surgery 23 (4) (2019)
Christine Fahim, Ben Whan Kim, Marc Bourcier, Steven J Glassman, Melinda J Gooderham, Lyn Guenther, Wayne Gulliver, Charles Lynde, Yves Poulin, Melanie Pratt, Neil H Shear, Ronald B Vender, Scott Walsh, Simone Fahim
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study. Journal of cutaneous medicine and surgery 23 (3) (2019)
Asma Amir Ali, Reid Vender, Ronald B Vender
The Role of IL-17 in Papulopustular Rosacea and Future Directions. Journal of cutaneous medicine and surgery 23 (6) (2019)
Ronald B Vender, Melinda J Gooderham, Lyn C Guenther, Dimitrios Kyritsis, Jaggi Rao, Alice Kowalczyk, John Ashkenas
Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys. Journal of cutaneous medicine and surgery 22 (5) (2018)
Ronald B Vender, M J Gooderham, L C Guenther, D Kyritsis, J Rao, A Kowalczyk, J Ashkenas
Psoriasis patients' preference for an aerosol foam topical formulation. Journal of the European Academy of Dermatology and Venereology : JEADV 32 (11) (2018)
Arnon D Cohen, J J Wu, Lluis L Puig, S Chimenti, Ronald B Vender, M Rajagopalan, R Romiti, C de la Cruz, L Skov, C Zachariae, Helen S Young, P Foley, J M van der Walt, L Naldi, E P Prens, Andrew Blauvelt
Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice. The British journal of dermatology 177 (6) (2017)

Ronald B Vender.css-eqlu8i{font-size:small;padding-left:4px;} (Ron Vender, R Vender, Ronald Vender, R B Vender, Ron B Vender)

Publication Activity (10 Years)

Top Topics

Top Venues

Ronald B Vender (Ron Vender, R Vender, Ronald Vender, R B Vender, Ron B Vender)